We are live on ! Find out more
CA

Cullinan Associates Portfolio holdings

AUM $1.24B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+28.12%
3 Year Est. Return
+86.66%
5 Year Est. Return
+111.98%
10 Year Est. Return
+372.59%
AUM
$1.36B
AUM Growth
+$63.4M
Cap. Flow
-$63.7M
Cap. Flow %
-4.68%
Top 10 Hldgs %
43.84%
Holding
197
New
3
Increased
50
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$17.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$2.08M
3
BNY
Bank of New York Mellon
BNY
+$1.4M
4
NEE icon
NextEra Energy
NEE
+$1.4M
5
MET icon
MetLife
MET
+$1.35M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$9.8M
2
PG icon
Procter & Gamble
PG
+$7.29M
3
WMT icon
Walmart Inc
WMT
+$5.81M
4
MMM icon
3M
MMM
+$4.54M
5
GE icon
GE Aerospace
GE
+$3.95M

Sector Composition

Rank Sector Weight
1 Consumer Staples 31.94%
2 Technology 13.38%
3 Financials 12.52%
4 Healthcare 10.12%
5 Communication Services 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TFC icon
26
Truist Financial
TFC
$63.2B
$11M 0.81%
220,633
-4,140
-2% -$200K
USB icon
27
US Bancorp
USB
$99.6B
$10.7M 0.79%
199,662
+1,060
+0.5% +$57K
AFL icon
28
Aflac
AFL
$63.9B
$10.6M 0.78%
242,400
-6,200
-2% -$265K
DIS icon
29
Walt Disney
DIS
$165B
$10.5M 0.77%
97,951
-1,520
-2% -$157K
TXN icon
30
Texas Instruments
TXN
$255B
$10.4M 0.76%
99,133
-18,867
-16% -$1.84M
JD icon
31
JD.com
JD
$40.8B
$10.4M 0.76%
249,900
– –
ORCL icon
32
Oracle
ORCL
$331B
$10.3M 0.75%
216,915
+17,195
+9% +$843K
MXIM
33
DELISTED
Maxim Integrated Products
MXIM
$10M 0.74%
191,701
-17,700
-8% -$920K
MMM icon
34
3M
MMM
$89B
$10M 0.74%
50,910
-23,577
-32% -$4.54M
CVX icon
35
Chevron
CVX
$388B
$9.74M 0.72%
77,821
-12,000
-13% -$1.42M
MRK icon
36
Merck
MRK
$324B
$9.29M 0.68%
172,984
-68,330
-28% -$3.79M
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$9.07M 0.67%
33,975
-2,513
-7% -$654K
MON
38
DELISTED
Monsanto Co
MON
$8.26M 0.61%
70,760
-4,440
-6% -$528K
MDT icon
39
Medtronic
MDT
$107B
$8.21M 0.6%
101,616
-1,970
-2% -$158K
UNH icon
40
UnitedHealth
UNH
$382B
$8.19M 0.6%
37,140
-870
-2% -$184K
VZ icon
41
Verizon
VZ
$194B
$8.08M 0.59%
152,705
-350
-0.2% -$17.2K
CVS icon
42
CVS Health
CVS
$137B
$7.83M 0.58%
108,075
-10,593
-9% -$770K
YUM icon
43
Yum! Brands
YUM
$41B
$7.62M 0.56%
93,310
+7,630
+9% +$604K
BMY icon
44
Bristol-Myers Squibb
BMY
$127B
$7.46M 0.55%
121,696
-6,500
-5% -$407K
SCHW
45
Charles Schwab
SCHW
$177B
$7.28M 0.53%
141,700
+14,700
+12% +$691K
ADBE icon
46
Adobe
ADBE
$89.5B
$7.28M 0.53%
41,520
-1,120
-3% -$193K
COF icon
47
Capital One
COF
$124B
$7.27M 0.53%
72,995
-12,000
-14% -$1.1M
CL icon
48
Colgate-Palmolive
CL
$72.6B
$7.02M 0.52%
93,080
-3,500
-4% -$256K
BYD icon
49
Boyd Gaming
BYD
$6.47B
$6.83M 0.5%
195,000
– –
AXP icon
50
American Express
AXP
$223B
$6.67M 0.49%
67,127
-22,100
-25% -$2.1M
1
2
3 4 5

Similar funds

WTA
Washington Trust Advisors Wellesley, Massachusetts $1.24B AUM 22.58% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
GX
Greylock XIV Menlo Park, California $1.24B AUM
HCA
Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
CCA
Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return
FLII
First Long Island Investors Jericho, New York $1.23B AUM 14.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Cullinan Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Cullinan Associates held 197 positions worth $1.36B, up 4.9% from $1.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cullinan Associates withdrew a net $63.7M in Q4 2017, closing 12 positions and reducing 102 holdings. Its most notable exit was Valero Energy, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Cullinan Associates opened a new position in VALEANT PHARMACEUTICALS INTL worth $935K.

  • Cullinan Associates's largest Q4 2017 buy was VALEANT PHARMACEUTICALS INTL: 45,000 shares worth $935K.
  • Cullinan Associates added most to S&P Global in Q4 2017, an estimated $17.1M increase.
  • Cullinan Associates's biggest Q4 2017 reduction was Abbott, cutting an estimated $9.8M.
  • Cullinan Associates fully exited Valero Energy in Q4 2017, selling an estimated $3.57M.
  • Cullinan Associates's ten largest holdings make up 44% of its $1.36B portfolio in Q4 2017.
  • Cullinan Associates opened 3 new positions and closed 12 in Q4 2017.
  • Cullinan Associates's portfolio value rose 4.9% quarter-over-quarter to $1.36B.

Based on Cullinan Associates's 13F filing for Q4 2017, filed 17 Jan 2018.